ATE522523T1 - 1,3,5-trisubstituiertes triazolderivat - Google Patents

1,3,5-trisubstituiertes triazolderivat

Info

Publication number: ATE522523T1
Authority: AT; Austria
Prior art keywords: triazole derivative; trisubstituted; trisubstituted triazole; derivative; triazole
Prior art date: 2007-10-18

Application number

AT08805280T

Other languages

English (en)

Inventor

Johannes Thuring

Theodorus Dinklo

Anne Lesage

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-18

Filing date

2008-10-15

Publication date

2011-09-15

2008-10-15 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE522523T1 publication Critical patent/ATE522523T1/de

Links

-1 1,3,5-TRISUBSTITUTED TRIAZOLE Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT08805280T 2007-10-18 2008-10-15 1,3,5-trisubstituiertes triazolderivat ATE522523T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07118822		2007-10-18
PCT/EP2008/063844 WO2009050185A1 (en)	2007-10-18	2008-10-15	1,3,5-trisubstituted triazole derivative

Publications (1)

Publication Number	Publication Date
ATE522523T1 true ATE522523T1 (de)	2011-09-15

Family

ID=39047591

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08805280T ATE522523T1 (de)	2007-10-18	2008-10-15	1,3,5-trisubstituiertes triazolderivat

Country Status (18)

Country	Link
US (1)	US8404851B2 (de)
EP (1)	EP2205594B1 (de)
JP (1)	JP2011500624A (de)
CN (1)	CN101827839B (de)
AR (1)	AR068919A1 (de)
AT (1)	ATE522523T1 (de)
AU (1)	AU2008313775B2 (de)
CA (1)	CA2697982C (de)
CL (1)	CL2008003067A1 (de)
ES (1)	ES2371863T3 (de)
IL (1)	IL205102A (de)
JO (1)	JO2784B1 (de)
MX (1)	MX2010004176A (de)
PA (1)	PA8799901A1 (de)
PE (1)	PE20091080A1 (de)
RU (1)	RU2476433C2 (de)
TW (1)	TW200934491A (de)
WO (1)	WO2009050185A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA97257C2 (en) *	2006-10-19	2012-01-25	Такеда Фармасьютикал Компани Лимитед	Indole derivatives
JP2011500625A (ja) *	2007-10-18	2011-01-06	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	トリ置換された１，２，４−トリアゾール
MY152486A (en) *	2008-03-19	2014-10-15	Janssen Pharmaceutica Nv	Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
WO2009135944A1 (en) *	2008-05-09	2009-11-12	Janssen Pharmaceutica Nv	Trisubstituted pyrazoles as acetylcholine receptor modulators
CA2825519A1 (en)	2011-02-03	2012-09-08	Lupin Limited	Pyrrole derivatives used as modulators of alpha7 nachr
RS55433B1 (sr)	2011-02-23	2017-04-28	Lupin Ltd	Derivati heteroarila kao modulatori nachr alfa7
CN103402983B (zh)	2011-02-25	2015-12-23	詹森药业有限公司	作为α7nAChR的别构调节剂的(吡啶-4-基)苄基酰胺
AU2012235779B2 (en)	2011-03-31	2017-03-02	Lupin Limited	Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as Alzheimer's and Parkinson's disease
US8946432B2 (en)	2011-07-05	2015-02-03	Lupin Limited	Biaryl derivatives as nAChR modulators
NZ629453A (en)	2012-03-06	2016-04-29	Lupin Ltd	Thiazole derivatives as alpha 7 nachr modulators
EP2945936A1 (de)	2012-11-12	2015-11-25	Lupin Limited	Thiazolderivate als alpha-7-nachr-modulatoren
EP2945941B1 (de)	2013-01-16	2016-12-07	Lupin Limited	Pyrrolderivate als alpha-7-nachr-modulatoren
US9617210B2 (en)	2013-03-13	2017-04-11	Lupin Limited	Pyrrole derivatives as alpha 7 NACHR modulators
TW201446243A (zh)	2013-06-03	2014-12-16	Lupin Ltd	4-(5-(4-氯苯基)-2-(2-環丙基乙醯基)-1,4-二甲基-1氫-吡咯-3-基)苯磺醯胺作為α7尼古丁乙醯膽鹼受體調節劑
WO2014203150A1 (en)	2013-06-17	2014-12-24	Lupin Limited	Pyrrole derivatives as alpha 7 nachr modulators

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE795907A (fr) *	1972-02-25	1973-06-18	Luso Farmaco Inst	2-amino-4-arylthiazoles 5-substitues et leur preparation
DE3773746D1 (en)	1986-05-07	1991-11-21	Fisons Plc	Pyrazole.
JPS6339868A (ja)	1986-08-04	1988-02-20	Otsuka Pharmaceut Factory Inc	ジ低級アルキルフエノ−ル誘導体
US4761422A (en)	1986-11-20	1988-08-02	Lusofarmaco Istituto Lusofarmaco D'italia Spa	(2-amino-4-aryl-thiazole-5-yl)ethanols and their derivatives having diuretic activity and methods for preparing the same
WO1996003392A1 (en)	1994-07-27	1996-02-08	G.D. Searle & Co.	Substituted thiazoles for the treatment of inflammation
BR9606546A (pt)	1995-08-02	1998-07-14	Uriach & Cia Sa J	Novas carboxamidas com atividade fungicida
FR2754258B1 (fr)	1996-10-08	1998-12-31	Sanofi Sa	Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
US6187797B1 (en) *	1996-12-23	2001-02-13	Dupont Pharmaceuticals Company	Phenyl-isoxazoles as factor XA Inhibitors
ES2196396T3 (es)	1996-12-23	2003-12-16	Bristol Myers Squibb Pharma Co	Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
ATE257703T1 (de)	1997-10-27	2004-01-15	Takeda Chemical Industries Ltd	1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes
FR2792314B1 (fr)	1999-04-15	2001-06-01	Adir	Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1070708B1 (de) *	1999-07-21	2004-01-14	F. Hoffmann-La Roche Ag	Triazolderivate
WO2001010865A1 (en)	1999-08-06	2001-02-15	Takeda Chemical Industries, Ltd.	p38MAP KINASE INHIBITORS
FR2802530B1 (fr)	1999-12-17	2002-02-22	Sanofi Synthelabo	Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
ATE414079T1 (de)	2000-03-01	2008-11-15	Janssen Pharmaceutica Nv	2,4-disubstituierte thiazolyl derivate
AU2001249670A1 (en)	2000-04-03	2001-10-15	3-Dimensional Pharmaceuticals, Inc.	Substituted thiazoles and the use thereof as inhibitors of plasminogen activatorinhibitor-1
HUP0303038A2 (hu)	2000-09-21	2003-12-29	Bristol-Myers Squibb Co.	Szubsztituált azolszármazékok mint kortikotropin releasing faktor inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
GB0028383D0 (en)	2000-11-21	2001-01-03	Novartis Ag	Organic compounds
CA2432870A1 (en)	2000-12-22	2002-07-25	Ronghui Lin	Substituted triazole diamine derivatives as kinase inhibitors
EA007717B1 (ru)	2001-08-13	2006-12-29	Янссен Фармацевтика Н.В.	2-амино-4,5-тризамещенные производные тиазолила
EP1441732A2 (de) *	2001-11-08	2004-08-04	Fujisawa Pharmaceutical Co., Ltd.	Thiazolderivat und seine pharmazeutische anwendung
CA2474322A1 (en)	2002-01-25	2003-07-31	Kylix Pharmaceuticals B.V.	4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
MXPA04004037A (es) *	2002-01-28	2004-07-23	Fuji Yakuhin Co Ltd	Compuestos novedosos de 1, 2, 4-de triazol.
ATE348831T1 (de)	2002-05-07	2007-01-15	Neurosearch As	Diazabicyclische biarylderivate
MXPA05000962A (es) *	2002-07-29	2005-05-16	Hoffmann La Roche	Nuevos benzodioxoles.
AR042052A1 (es) *	2002-11-15	2005-06-08	Vertex Pharma	Diaminotriazoles utiles como inhibidores de proteinquinasas
US20070191267A1 (en)	2003-04-28	2007-08-16	Ab Science	Use of tyrosine kinase inhibitors for treating cerebral ischemia
EP1628666B1 (de)	2003-05-14	2015-09-23	NeuroGenetic Pharmaceuticals, Inc.	Verbindungen und ihre verwendungen zur modulierung von amyloid beta
AU2004251668B2 (en) *	2003-06-03	2008-03-20	Triad Therapeutics, Inc	5-membered heterocycle-based p-38 inhibitors
EP1648876A1 (de) *	2003-07-24	2006-04-26	Pharmagene Laboratories Ltd	5-ht sb 2b/sb rezeptor-antagonisten
FR2862647B1 (fr)	2003-11-25	2008-07-04	Aventis Pharma Sa	Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
GB0401336D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
CN1942450A (zh) *	2004-02-11	2007-04-04	詹森药业有限公司	取代三唑化合物的制备方法
MX2007003154A (es) *	2004-09-17	2007-05-15	Vertex Pharma	Compuestos de diaminotriazol de utilidad como inhibidores de proteina quinasa.
ATE485042T1 (de)	2004-10-21	2010-11-15	Vertex Pharma	Triazole als hemmer von proteinkinasen
WO2006064375A2 (en)	2004-12-16	2006-06-22	Ab Science	Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases
AU2006206611A1 (en) *	2005-01-19	2006-07-27	Bristol-Myers Squibb Company	2-phenoxy-N- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as P2Y1 receptor inhibitors for the treatment of thromboembolic disorders
NZ566036A (en) *	2005-09-13	2010-06-25	Janssen Pharmaceutica Nv	2-Aniline-4-aryl substituted thiazole derivatives that modulate the alpha7 nicotinic receptor
JO3019B1 (ar) *	2006-04-19	2016-09-05	Janssen Pharmaceutica Nv	ثلاثي مستبدل 4،2،1-ثلاثي زولات
JP2011500625A (ja) *	2007-10-18	2011-01-06	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	トリ置換された１，２，４−トリアゾール
MY152486A (en) *	2008-03-19	2014-10-15	Janssen Pharmaceutica Nv	Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
CL2009000916A1 (es)	2008-04-17	2010-12-31	Glaxo Group Ltd	Compuestos derivados de 2-trifluorometil-1h-indol-5-metilcarboxamida, moduladores del receptor nicotinico de acetilcolina alfa7 (nachr); composicon farmaceutica; y uso para el tratamiento del deterioro cognitivo y de un trastorno psicotico como esquizofrenia.
WO2009135944A1 (en) *	2008-05-09	2009-11-12	Janssen Pharmaceutica Nv	Trisubstituted pyrazoles as acetylcholine receptor modulators
CN102574832B (zh) *	2009-09-17	2014-09-24	詹森药业有限公司	取代的n-苯基-1-(4-吡啶基)-1h-吡唑-3-胺
JO3078B1 (ar) *	2009-11-27	2017-03-15	Janssen Pharmaceutica Nv	مورفولينوثيازولات بصفتها منظمات الوستيرية نوع الفا 7 موجبة
CN103402983B (zh)	2011-02-25	2015-12-23	詹森药业有限公司	作为α7nAChR的别构调节剂的(吡啶-4-基)苄基酰胺

2008
- 2008-09-15 JO JO2008412A patent/JO2784B1/en active
- 2008-10-15 JP JP2010529360A patent/JP2011500624A/ja active Pending
- 2008-10-15 ES ES08805280T patent/ES2371863T3/es active Active
- 2008-10-15 RU RU2010119458/04A patent/RU2476433C2/ru active
- 2008-10-15 AU AU2008313775A patent/AU2008313775B2/en not_active Ceased
- 2008-10-15 WO PCT/EP2008/063844 patent/WO2009050185A1/en not_active Ceased
- 2008-10-15 CN CN2008801119538A patent/CN101827839B/zh not_active Expired - Fee Related
- 2008-10-15 AT AT08805280T patent/ATE522523T1/de not_active IP Right Cessation
- 2008-10-15 US US12/738,725 patent/US8404851B2/en not_active Expired - Fee Related
- 2008-10-15 EP EP08805280A patent/EP2205594B1/de active Active
- 2008-10-15 CA CA2697982A patent/CA2697982C/en not_active Expired - Fee Related
- 2008-10-15 MX MX2010004176A patent/MX2010004176A/es active IP Right Grant
- 2008-10-16 CL CL2008003067A patent/CL2008003067A1/es unknown
- 2008-10-17 PE PE2008001789A patent/PE20091080A1/es active IP Right Grant
- 2008-10-17 AR ARP080104545A patent/AR068919A1/es not_active Application Discontinuation
- 2008-10-17 TW TW097139807A patent/TW200934491A/zh unknown
- 2008-10-17 PA PA20088799901A patent/PA8799901A1/es unknown
2010
- 2010-04-15 IL IL205102A patent/IL205102A/en active IP Right Grant

Also Published As

Publication number	Publication date
PE20091080A1 (es)	2009-08-03
TW200934491A (en)	2009-08-16
RU2476433C2 (ru)	2013-02-27
AU2008313775B2 (en)	2012-12-13
IL205102A0 (en)	2010-11-30
CA2697982C (en)	2015-09-22
EP2205594B1 (de)	2011-08-31
EP2205594A1 (de)	2010-07-14
JP2011500624A (ja)	2011-01-06
CN101827839A (zh)	2010-09-08
CN101827839B (zh)	2012-10-24
PA8799901A1 (es)	2009-05-15
MX2010004176A (es)	2010-05-03
CL2008003067A1 (es)	2009-11-27
AU2008313775A1 (en)	2009-04-23
RU2010119458A (ru)	2011-11-27
US20100240707A1 (en)	2010-09-23
US8404851B2 (en)	2013-03-26
ES2371863T3 (es)	2012-01-10
WO2009050185A1 (en)	2009-04-23
CA2697982A1 (en)	2009-04-23
IL205102A (en)	2015-04-30
AR068919A1 (es)	2009-12-16
JO2784B1 (en)	2014-03-15

Legal Events

Date	Code	Title	Description
2012-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
IL205102A0 (en)	2010-11-30	1,3,5 - trisubstituted triazole derivative
ATE502012T1 (de)	2011-04-15	1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivat
BRPI0811718A2 (pt)	2014-11-18	Derivados de 3,3-espiroindolinona
BRPI0816970A2 (pt)	2015-03-24	1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
ATE555107T1 (de)	2012-05-15	2-aza-bicyclo-ä2,2,1-üheptan-derivate
EP2194045A4 (de)	2011-09-21	Substituiertes pyrazolderivat
BRPI0923786A2 (pt)	2016-07-26	compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
AP2377A (en)	2012-03-07	Benzimidazole derivatives.
ATE469145T1 (de)	2010-06-15	4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl-
BRPI0816461A2 (pt)	2015-03-24	Derivados fungicidas de 2-alquiltio-2-quinolonolóxi-acetamida
IL206765A0 (en)	2010-12-30	4,5-dihydro-oxazol-2-yl-amine derivatives
ATE481383T1 (de)	2010-10-15	3-aza-bicycloä3.1.0ühexanderivate
BRPI0816408A2 (pt)	2015-03-03	Fungicidas.
EP1988083A4 (de)	2009-11-11	Triazolderivat
IL225694A0 (en)	2013-06-27	Compounds 6,5- dihydro-h1-pyridine-2-one
BRPI0815059A2 (pt)	2015-02-10	Derivado de 1,3-di-hidroisoindol
EP2222161A4 (de)	2011-09-28	Chinoxalinylderivate
DE602007001681D1 (de)	2009-09-03	1,3-dioxan-carboxylsäuren
BRPI0916363A2 (pt)	2018-05-29	derivados de 4,5-di-hidro-oxazol-2-ila
BRPI0821357A2 (pt)	2017-05-23	derivados de oxadiazois de triazol
BRPI0916395A2 (pt)	2016-02-16	compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
EP2258697A4 (de)	2011-08-03	Hydroxychinoxalincarboxamidderivat
EP2202231A4 (de)	2011-09-28	2,3-dihydroiminoisoindolderivate
DK2241564T3 (da)	2014-05-19	3,8-diaminotetrahydroquinolin-derivat
IL201444A0 (en)	2010-06-16	New 4, 8 - diphenyl - polyazanaphthalene derivatives